Ignite Creation Date:
2025-12-24 @ 1:33 PM
Ignite Modification Date:
2026-01-01 @ 8:51 PM
Study NCT ID:
NCT03256695
Status:
COMPLETED
Last Update Posted:
2021-11-09
First Post:
2017-08-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD)
Sponsor:
Teva Branded Pharmaceutical Products R&D, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-09-28
Start Date Type:
ACTUAL
Primary Completion Date:
2018-04-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-04-17
Completion Date Type:
ACTUAL
First Submit Date:
2017-08-18
First Submit QC Date:
None
Study First Post Date:
2017-08-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2019-06-04
Results First Submit QC Date:
None
Results First Post Date:
2019-08-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-11-05
Last Update Post Date:
2021-11-09
Last Update Post Date Type:
ACTUAL